Literature DB >> 3361165

Hyperthermic effect of centrally administered bradykinin in the rat: role of prostaglandins and serotonin.

P J Rao1, S K Bhattacharya.   

Abstract

Intracerebroventricularly administered bradykinin (2.5, 5 and 10 micrograms/rat) produced a dose-related increase in the rectal temperature of adult Wistar strain albino rats. The bradykinin-induced hyperthermia was significantly attenuated following pretreatment of the animals with pharmacological agents which selectively reduce rat brain serotonin or prostaglandin (PG) activity. These findings, and those of earlier reports emanating from this laboratory which indicate that centrally administered bradykinin augments rat brain serotonin and PGE2 activity, suggest the involvement of PGs and serotonin in the hyperthermic action of bradykinin in this species.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3361165     DOI: 10.3109/02656738809029308

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  4 in total

1.  Development of hyperthermia following intracerebroventricular administration of endotoxin in the rat: effect of kinin B1 and B2 receptor antagonists.

Authors:  K Walker; A Dray; M Perkins
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

2.  Central B2 receptor involvement in the antinociceptive effect of bradykinin in rats.

Authors:  I R Pelá; A L Rosa; C A Silva; J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

3.  Activation of kinin B1 receptor evokes hyperthermia through a vagal sensory mechanism in the rat.

Authors:  Sébastien Talbot; Helaine De Brito Gariépy; Julien Saint-Denis; Réjean Couture
Journal:  J Neuroinflammation       Date:  2012-09-13       Impact factor: 8.322

4.  The bradykinin system in stress and anxiety in humans and mice.

Authors:  Ari Rouhiainen; Natalia Kulesskaya; Marie Mennesson; Zuzanna Misiewicz; Tessa Sipilä; Ewa Sokolowska; Kalevi Trontti; Lea Urpa; William McEntegart; Suvi Saarnio; Petri Hyytiä; Iiris Hovatta
Journal:  Sci Rep       Date:  2019-12-19       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.